FDA Classifies Nasal Devices, Exempts from Pre-Market Notification Requirements

Summary

The FDA is classifying the nasal dilator, intranasal splint, and bone particle collector into Class I (general controls) and exempting them from premarket notification requirements, as mandated by the Federal Food, Drug, and Cosmetic Act and other relevant legislation.